January 2025 FDA Recall Drug by Direct Rx
D-0364-2025 - Defective Container

This Class II drug recall was voluntarily initiated by Direct Rx on January 31, 2025 for the product Drug. The FDA reported the reason for recall as defective container. The product was distributed in Physicians and medical facilities in 5 states: AL, CA, FL, GA, ID and the recall is currently ongoing.

Recall Number: D-0364-2025

Reason for Recall
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Initiated
01-31-2025
Reported
04-23-2025
Quantity
477 bottles.

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Physicians and medical facilities in 5 states: AL, CA, FL, GA, ID
CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and Distributed by: DIRECT Rx, NDC 61919-795-05.

Batch or Lot Expiration Information

Lot# Lot 11SE2402, Exp Date: 11/30/2025 Lot 14NO2406, Exp Date: 12/31/2025 Lot 29OC2420, Exp Date: 11/30/2025 Lot 30SE2412, Exp Date: 11/30/2025